SCHEMBL6673530

SCHEMBL6673530

Cn1ccnc1OC(N)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.39
CHRNA4 P43681 1/20 0.39
LPO P22079 1/20 0.38
FDPS P14324 2/20 0.34
RAB9A P51151 3/20 0.33
NPC1 O15118 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KMT2A Q03164 3/20 0.33
MYC P01106 1/20 0.33
LMNA P02545 1/20 0.33
NAMPT P43490 1/20 0.33
TSHR P16473 1/20 0.32
ALDH1A1 P00352 2/20 0.32
MEN1 O00255 1/20 0.32
TP53 P04637 1/20 0.32
POLB P06746 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
ALOX12 P18054 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1682004 0.82 CHRNB2 (0.40) CHRNB2CHRNA4LPOFDPSRAB9A
SCHEMBL28386445 0.82 CHRNB2 (0.40) CHRNB2CHRNA4LPOFDPSRAB9A
SCHEMBL16991360 0.80 CHRNB2 (0.40) CHRNB2CHRNA4LPOFDPSRAB9A
SCHEMBL28324902 0.77 CHRNB2 (0.36) CHRNB2CHRNA4LPOFDPSRAB9A
SCHEMBL2285950 0.77 KMT2A (0.39) CHRNB2CHRNA4LPOFDPSRAB9A
SCHEMBL29062266 0.77 ALDH1A1 (0.40) LMNAALDH1A1
SCHEMBL2804720 0.74 KMT2A (0.52) SMN1; SMN2KMT2ALMNATSHRALDH1A1
SCHEMBL26112999 0.73 ELANE (0.39) CHRNB2CHRNA4MAPT
SCHEMBL20195592 0.73
SCHEMBL30689360 0.72 PARP10 (0.54) RAB9ANPC1KMT2AMYCALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465613-A2 COMBINATION OF MTP INHIBITORS OR APOB SECRETION INHIBITORS WITH FIBRATES FOR USE AS DRUGS Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2004-10-13 EP disclosed
WO-2003057205-A2 COMBINATION OF MTP INHIBITORS OR APOB SECRETION INHIBITORS WITH FIBRATES FOR USE AS DRUGS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-07-17 WO disclosed